What is the purpose of imatinib 100mg Tablet Nutab?
Imatinib 100mg Tablet Nutab is a drug that is used to treat some types of leukemia (cancer that starts in the white blood cells) as well as other malignancies and blood cell abnormalities.
What is the purpose of the medicine imatinib?
Imatinib 100mg Tablet Nutab, also known by the brand name Glivec, is a targeted cancer treatment (biologic therapy) (pronounced glee-vec). It is a cancer treatment that is used to treat a variety of cancers.
Imatinib is used to treat a variety of malignancies.
Acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative disorders are among the cancers treated with this drug. It works by delaying or stopping the multiplication of cancer cells.
What are the Imatinib 100mg Tablet Nutab side effects?
- Pain, cramping, burning, or soreness in the abdomen or stomach.
- After surgery, there is bleeding from the wound.
- There are issues with bleeding.
- Face, hands, lower legs, or feet bloating or edoema
- Urine with blood in it.
- bloodshot eye
- a nasal bleed
- Lips and fingernails are blue. For more details Click Here.
Imatinib should not be taken by anyone
If you are pregnant, avoid using imatinib.
It has the potential to harm the unborn child or cause birth abnormalities. Prevent pregnancy while taking this medicine and for at least 14 days after your last dosage by using effective birth control.
Is imatinib a drug that weakens the immune system?
Furthermore, Imatinib 100mg Tablet Nutab has been shown to impact the function and development of antigen-presenting cells as well as limit the effector functions of T lymphocytes in various in vitro studies and animal models.
When will I be able to stop taking imatinib?
Patients with chronic myeloid leukemia (CML) who have had the undetectable minimal residual disease (UMRD) for at least two years can safely stop using imatinib (IM). The Stop Imatinib (STIM1) study’s final results with an extended follow-up are presented.
Is imatinib a protein or a peptide?
The Philadelphia chromosome causes bcr-abl, a fusion protein of abl and bcr (breakpoint cluster region) in chronic myelogenous leukemia. Imatinib is used to reduce bcr-abl activity since it is now a constitutively active tyrosine kinase.